3 ms·
CONCLUSIONS Treatment with ivermectin did not result in a lower incidence of medical admission to a hospital due to progression of Covid-19 or of prolonged emer
by slv77 3y ago
CONCLUSIONS
Treatment with ivermectin did not result in a lower incidence of medical admission to a hospital due to progression of Covid-19 or of prolonged emergency department observation among outpatients with an early diagnosis of Covid-19. (Funded by FastGrants and the Rainwater Charitable Foundation; TOGETHER ClinicalTrials.gov number, NCT04727424. opens in new tab.)
https://www.nejm.org/doi/full/10.1056/nejmoa2115869 https://www.nejm.org/doi/full/10.1056/nejmoa2115869
- CamperBob2 3y agoHe doesn't care. Someone else got to him first.
- GenerocUsername 3y agoThis study has flaws. Namely, the ivermectin was only administered with patients after 7 days of symptomatic COVID infection. Meanwhile Paxlovid, the patented ACE2 inhibitor is received as a proven treatment when administered early in infection. 7 days after symptoms appear is not early. The game is rigged my friend